RIM
VRTX icon

Rampart Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Rampart Investment Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,641
Closed -$447K – 357
2020
Q3 		$447K Sell
1,641
-3,593
-69% -$991K 0.28% 85
2020
Q2 		$1.52M Buy
5,234
+1,419
+37% +$385K 0.26% 107
2020
Q1 		$908K Buy
3,815
+780
+26% +$179K 0.43% 54
2019
Q4 		$665K Buy
3,035
+121
+4% +$24.5K 0.08% 268
2019
Q3 		$494K Sell
2,914
-55
-2% -$9.73K 0.06% 309
2019
Q2 		$544K Sell
2,969
-154
-5% -$26.9K 0.06% 302
2019
Q1 		$574K Buy
3,123
+402
+15% +$74.3K 0.07% 297
2018
Q4 		$451K Sell
2,721
-3,491
-56% -$605K 0.13% 159
2018
Q3 		$546K Sell
6,212
-1,282
-17% -$228K 0.24% 104
2018
Q2 		$1.27M Buy
7,494
+741
+11% +$115K 0.12% 230
2018
Q1 		$1.1M Buy
6,753
+3,653
+118% +$597K 0.11% 236
2017
Q4 		$465K Sell
3,100
-312
-9% -$46.2K 0.18% 133
2017
Q3 		$519K Buy
3,412
+117
+4% +$17.6K 0.18% 132
2017
Q2 		$425K Buy
3,295
+2,619
+387% +$315K 0.15% 152
2017
Q1 		$74K Sell
676
-6,049
-90% -$533K 0.03% 194
2016
Q4 		$496K Sell
6,725
-22
-0.3% -$1.79K 0.18% 100
2016
Q3 		$588K Buy
+6,747
New +$638K 0.22% 88

Other funds holding VRTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Rampart Investment Management's VRTX Position: Q4 2020 in Review

Rampart Investment Management sold out of Vertex Pharmaceuticals (VRTX) in Q4 2020, closing a stake of 1,641 shares — an estimated $447K sold.

Rampart Investment Management first reported a position in VRTX in Q3 2016 and held it in 17 quarters. The position peaked at $1.52M in Q2 2020. 971 funds tracked by Wall St. Rank hold VRTX as of Q4 2020.

  • Rampart Investment Management reported no remaining Vertex Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Rampart Investment Management sold 1,641 Vertex Pharmaceuticals shares in Q4 2020, an estimated $447K.
  • Rampart Investment Management first reported a position in Vertex Pharmaceuticals in Q3 2016 and held it in 17 quarters.
  • Rampart Investment Management's Vertex Pharmaceuticals position peaked at $1.52M in Q2 2020.
  • 971 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2020.

Based on Rampart Investment Management's 13F filing for Q4 2020.